Terri Lynn Shigle

Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients

Farnaz Foolad, Samuel L Aitken, Terri Lynn Shigle et al. · Clinical Infectious Diseases · 2018 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era

Joseph Sassine, Fareed Khawaja, Terri Lynn Shigle et al. · Clinical Infectious Diseases · 2021 · 86 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation

Michelle K. Yong, Terri Lynn Shigle, Yae‐Jean Kim et al. · Transplantation and Cellular Therapy · 2021 · 68 citations

Medicine, Hematology, Infectious Diseases +17

Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer

Minas P. Economides, Parag Mahale, Andreas Kyvernitakis et al. · Alimentary Pharmacology & Therapeutics · 2016 · 51 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing <i>Escherichia coli</i> in Patients with Hematologic Malignancy

Grace Benanti, Anne Rain Brown, Terri Lynn Shigle et al. · Antimicrobial Agents and Chemotherapy · 2018 · 33 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17